Literature DB >> 18222360

Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation.

Ronen Beeri1, Chaim Yosefy, J Luis Guerrero, Francesca Nesta, Suzan Abedat, Miguel Chaput, Federica del Monte, Mark D Handschumacher, Robert Stroud, Suzanne Sullivan, Thea Pugatsch, Dan Gilon, Gus J Vlahakes, Francis G Spinale, Roger J Hajjar, Robert A Levine.   

Abstract

OBJECTIVES: We examined whether mitral regurgitation (MR) augments post-myocardial infarction (MI) remodeling.
BACKGROUND: MR doubles mortality after MI, but its additive contribution to left ventricular (LV) remodeling is debated and has not been addressed in a controlled fashion.
METHODS: Apical MIs were created in 12 sheep, and 6 had an LV-to-left atrial shunt implanted, consistently producing regurgitant fractions of approximately 30%. The groups were compared at baseline, 1, and 3 months.
RESULTS: Left ventricular end-systolic volume progressively increased by 190% with MR versus 90% without MR (p < 0.02). Pre-load-recruitable stroke work declined by 82 +/- 13% versus 25 +/- 16% (p < 0.01) with MR, with decreased remote-zone sarcoplasmic reticulum Ca(2+)-ATPase levels (0.56 +/- 0.03 vs. 0.76 +/- 0.02, p < 0.001), and decreased isolated myocyte contractility. In remote zones, pro-hypertrophic Akt and gp130 were upregulated in both groups at 1 month, but significantly lower and below baseline in the MR group at 3 months. Pro-apoptotic caspase 3 remained high in both groups. Matrix metalloproteinase (MMP)-13 and membrane-type MMP-1 were increased in remote zones of MR versus infarct-only animals at 1 month, then fell below baseline. The MMP tissue inhibitors rose from baseline to 3 months in all animals, rising higher in the MI + MR-group border zone.
CONCLUSIONS: In this controlled model, moderate MR worsens post-MI remodeling, with reduced contractility. Pro-hypertrophic pathways are initially upregulated but subsequently fall below infarct-only levels and baseline; with sustained caspase 3 elevation, transformation to a failure phenotype occurs. Extracellular matrix turnover increases in MR animals. Therefore, MR can precipitate an earlier onset of dilated heart failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18222360     DOI: 10.1016/j.jacc.2007.07.093

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  31 in total

Review 1.  Model-specific selection of molecular targets for heart failure gene therapy.

Authors:  Michael G Katz; Anthony S Fargnoli; Catherine E Tomasulo; Louella A Pritchette; Charles R Bridges
Journal:  J Gene Med       Date:  2011-10       Impact factor: 4.565

Review 2.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

3.  Mitral valve prolapse: a deeper look.

Authors:  Robert A Levine; Ronen Durst
Journal:  JACC Cardiovasc Imaging       Date:  2008-05

4.  Impact of posteromedial papillary muscle infarction on mitral regurgitation during ST-segment elevation myocardial infarction.

Authors:  Gert Klug; Hans-Josef Feistritzer; Sebastian J Reinstadler; Martin Reindl; Christina Tiller; Magdalena Holzknecht; Agnes Mayr; Silvana Müller; Axel Bauer; Bernhard Metzler
Journal:  Int J Cardiovasc Imaging       Date:  2019-11-09       Impact factor: 2.357

5.  Anticipating the Vicious Circle of Postinfarction Mitral Regurgitation: Imaging Insights.

Authors:  Jacob P Dal-Bianco; Philipp E Bartko; Robert A Levine
Journal:  Circ Cardiovasc Imaging       Date:  2016-07       Impact factor: 7.792

6.  Moderate mitral regurgitation accelerates left ventricular remodeling after posterolateral myocardial infarction.

Authors:  Mehrdad Soleimani; Michael Khazalpour; Guangming Cheng; Zhihong Zhang; Gabriel Acevedo-Bolton; David A Saloner; Rakesh Mishra; Arthur W Wallace; Julius M Guccione; Liang Ge; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2011-09-25       Impact factor: 4.330

7.  Impact of mitral regurgitation on exercise capacity and clinical outcomes in patients with ischemic left ventricular dysfunction.

Authors:  Catherine Szymanski; Robert A Levine; Christophe Tribouilloy; Hui Zheng; Mark D Handschumacher; Ahmed Tawakol; Judy Hung
Journal:  Am J Cardiol       Date:  2011-09-21       Impact factor: 2.778

8.  Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin.

Authors:  Elie R Chemaly; Soojeong Kang; Shihong Zhang; LaTronya McCollum; Jiqiu Chen; Ludovic Bénard; K-Raman Purushothaman; Roger J Hajjar; Djamel Lebeche
Journal:  J Physiol       Date:  2013-09-09       Impact factor: 5.182

9.  Mitral regurgitation after anteroapical myocardial infarction: new mechanistic insights.

Authors:  Chaim Yosefy; Ronen Beeri; J Luis Guerrero; Mordehay Vaturi; Marielle Scherrer-Crosbie; Mark D Handschumacher; Robert A Levine
Journal:  Circulation       Date:  2011-03-28       Impact factor: 29.690

10.  Mitral apparatus assessment by delayed enhancement CMR: relative impact of infarct distribution on mitral regurgitation.

Authors:  Jason S Chinitz; Debbie Chen; Parag Goyal; Sean Wilson; Fahmida Islam; Thanh Nguyen; Yi Wang; Sandra Hurtado-Rua; Lauren Simprini; Matthew Cham; Robert A Levine; Richard B Devereux; Jonathan W Weinsaft
Journal:  JACC Cardiovasc Imaging       Date:  2013-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.